Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

275 POSTS 0 COMMENTS

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56...

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with...

Apeiron and Other Key Shareholders of atai Life Sciences Reinforce Support...

atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial...

atai Life Sciences Has Been Selected for Addition to the NASDAQ...

atai Life Sciences launches TryptageniX to further expand atai’s robust intellectual...

atai Life Sciences Increases its Ownership Position in COMPASS Pathways

atai Life Sciences Reports Third Quarter 2021 Financial Results and Corporate...

atai Life Sciences to Host Conference Call and Webcast to Discuss...

June 2020 Newsletter

July 2020 Newsletter

EDITOR PICKS

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56...

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY